NASDAQ:RGEN
Repligen Corporation Stock News
$149.09
+0.91 (+0.614%)
At Close: May 31, 2024
Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters' Option
04:18pm, Thursday, 10'th Dec 2020
WALTHAM, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the closing of its previously announced underwritten public offering of an aggregate of 1.725 mill
Repligen Corporation Prices Public Offering of Shares of Common Stock
09:41pm, Monday, 07'th Dec 2020
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the pricing of an underwritten public offering of 1.5 million shares of its common stock at a publ
Repligen: A Cure For COVID-19
10:21am, Monday, 07'th Dec 2020
Repligen is a "pick-and-shovel" play in the bioprocessing industry. Repligen heavily invests in single-use products for use in downstream continuous manufacturing processes, which are two of the late
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
07:22am, Monday, 07'th Dec 2020
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of 1.5 million shares of its common stock. I
Repligen (RGEN) Looks Good: Stock Adds 6.1% in Session
08:31am, Friday, 13'th Nov 2020
Repligen (RGEN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks
08:15am, Friday, 13'th Nov 2020
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Why Shares of Repligen Soared in October
09:17am, Friday, 06'th Nov 2020
The bioprocessing technology company is having a great year.
Repligen Stock: This Little-Known Biotech Posts Record Results
05:15pm, Thursday, 05'th Nov 2020
Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for the company.
Repligen Corporation's (RGEN) CEO Tony Hunt on Q3 2020 Results - Earnings Call Transcript
03:23pm, Thursday, 05'th Nov 2020
Repligen Corporation's (RGEN) CEO Tony Hunt on Q3 2020 Results - Earnings Call Transcript
WALTHAM, Mass., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a
